Europe · stealth · biotech / AI
Yann Fleureau sold his cardiology AI firm to Philips then raised $25M to build microfluidic hardware that produces the single-cell perturbation data missing from cell foundation models.
Rivercell develops microfluidic instruments and closed-loop lab systems to generate interventional single-cell perturbation datasets. The company raised a $25M seed after founder Yann Fleureau sold Cardiologs to Philips.